全部分类
  • [Glu1]-Fibrinopeptide B
[Glu1]-Fibrinopeptide B的可视化放大

[Glu1]-Fibrinopeptide B

[Glu1]-FibrinopeptideB衍生自纤维蛋白肽B氨基酸残基1-14。人纤维蛋白肽B(hFpB)是来自纤维蛋白原Bβ链的凝血酶衍生的蛋白水解裂解产物,可用于刺激中性粒细胞(PMN),单核细胞和成纤维细胞。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

[Glu1]-Fibrinopeptide B的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 500ug
    ¥1287.00
    1030.00
    - +
  • 1mg
    ¥1937.00
    1550.00
    - +
  • 5mg
    ¥7700.00
    6160.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx13254
  • CAS: 103213-49-6
  • 别名: [Glu1]-纤维蛋白肽B
  • 分子式: C66H95N19O26
  • 分子量: 1570.6
  • 纯度: >98%
  • 溶解度: Soluble in Water
  • 储存: Store at -20°C
  • 库存: 现货

Background

[Glu1]-Fibrinopeptide B is derived from fibrinopeptide B amino acid residues 1-14. Human fibrinopeptide B (hFpB), a thrombin-derived proteolytic cleavage product of the fibrinogen B beta-chain, to stimulate neutrophils (PMN), monocytes, and fibroblasts.


hFpB causes directed cell migration of PMN and fibroblasts that is optimal at approximately 10 nM. hFpB causes a rapid, dose-dependent increase in PMN cytoskeletal associated actin, but unlike fMLP, hFpB does not cause PMN aggregation, release of lysosomal enzymes (lysozyme and beta-glucuronidase), or the production of superoxide anion. These results suggest that hFpB may have a role in recruiting PMN and fibroblasts at sites of fibrin deposition and turnover. The capacity of hFpB to cause PMN chemotaxis without causing concurrent release of lysosomal enzymes or the production of superoxide anion is further evidence for the complexity of PMN responses to chemotactic agents[1].


[1]. Senior RM, et al. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest. 1986 Mar;77(3):1014-9.

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算